{"nct_id":"NCT06065059","title":"Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors","status":"TERMINATED","status_verified_date":"2024-08","start_date":"2023-12-08","start_date_type":"ACTUAL","primary_completion_date":"2024-05-22","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-22","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TNGX"]}